about
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center studyBetween-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.Cyst-based measurements for assessing lymphangioleiomyomatosis in computed tomography.Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.Cardiac CT research: exponential growth.Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.Coronary calcium coverage score: determination, correlates, and predictive accuracy in the Multi-Ethnic Study of Atherosclerosis.The National Lung Screening Trial: overview and study design.Contemporary cardiac imaging: an overview.Monte Carlo simulations to assess the effects of tube current modulation on breast dose for multidetector CTDose to radiosensitive organs during routine chest CT: effects of tube current modulationCyclophosphamide versus placebo in scleroderma lung disease.Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement mapsA method for the automatic quantification of the completeness of pulmonary fissures: evaluation in a database of subjects with severe emphysemaImpact and costs of targeted recruitment of minorities to the National Lung Screening TrialQuantitative CT of emphysema and the airways.Solitary pulmonary nodule diagnosis on CT: results of an observer study.Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPredictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.Pulmonary circulation: contrast-enhanced 3.0-T MR angiography--initial results.High-resolution computed tomography of interstitial pulmonary fibrosis.Integrated multimedia timeline of medical images and data for thoracic oncology patients.Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study.A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation.Computer-aided diagnosis in lung nodule assessment.A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.Eosinophil and T cell markers predict functional decline in COPD patients.Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus.Update on radiology of emphysema and therapeutic implications.Cardiac dual-source CT for the preoperative assessment of patients undergoing bariatric surgery.A concept-based retrieval system for thoracic radiology.SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.The effect of radiation dose reduction on computer-aided detection (CAD) performance in a low-dose lung cancer screening population.Database design and implementation for quantitative image analysis research.Chronic obstructive pulmonary disease phenotypes: the future of COPD.Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
P50
Q30413713-39BDF517-A9FB-44C6-89E0-71326AFB5EC0Q30912628-E9E9D4DA-2044-43C2-B391-86CBFEC3028DQ30952452-546B4780-87DE-4DEB-A9C8-80B752F5FF04Q33434238-04016896-18AF-4BB7-8380-C745E66B2294Q33475538-8D02646D-DA20-4D5A-A778-41D94C8749E5Q33496405-1A12114A-3FF7-4BEF-A8F6-6BC26FE7FF33Q33599056-FE00D7C3-6CF2-4275-887C-19C383B4D45EQ33620455-C04D1FC4-17D3-4800-8708-93208FFE3870Q33736528-7CEDA77A-E4DC-4D30-9A36-195EEF479103Q34064752-EF67C5D0-71AA-4130-ADA3-0A62800146E5Q34169699-64C03B2F-2589-4DFA-9258-8FEB28D0DAA8Q34195461-8EDAE7C0-2B1B-4181-BD46-41DEBECEC16CQ34540647-74ED2856-DF1E-438D-BA80-0FC14EE7C06FQ35103773-1349ACF7-50F7-40A8-9528-291F0F1D120BQ35643500-067337F3-D391-4187-A958-4993129B0922Q35673393-D19934C9-674C-44A2-9D35-0888895BBF60Q35926821-8E3F6147-DB06-42D0-A302-2406BD9C9A44Q36098619-44A9086E-5810-4368-9CF4-4EC32D85D341Q36145795-E734A8A8-3A88-40EA-A0EE-C262BB0E4B37Q36171822-53343FB2-7EFC-4231-B077-5F9D02B3AA22Q36477472-72436203-3A22-45F8-9D7C-5A4F6D41F100Q36534632-3CCE8884-811B-4EDF-8F65-16938F98C4C2Q36694867-B229658D-A888-4F25-A115-EC6629ACCEAFQ36830286-19E3E750-88B0-4923-9654-FE7FECDEAA9DQ36976489-16AFBEB7-DA77-4F6F-A72B-A0A2A510A6D6Q37119845-47B39654-984C-4115-81A2-E4D2786BE2DCQ37180411-C04BEA33-FEAC-412E-BF56-833C47B72FCAQ37241549-8A5A9088-8576-4D0B-9BA1-2AA1765C0AA1Q37242235-13593633-ECA8-4231-8141-7F9814648DE8Q37448511-B9BE0590-692C-4729-B655-F1414C5D85C5Q37473215-9B74EC51-D692-4992-8E95-AB585098DB46Q37575241-2544BEA4-2C06-4A77-B834-63DF28F9C204Q38070439-C1D53DC6-9837-4423-8017-7080D9BE92D9Q38561961-32FD969B-E1F2-4C37-B760-C61E312C9693Q38835357-039D28D0-2A16-4C84-A36D-92436C870CC0Q38999643-C398F9B4-39D8-4997-8D64-E9C0CCB89BAEQ39711576-149E6F9B-96DC-4182-9622-22BDBCE94695Q39867138-A1A43C1D-0758-406A-9B47-0F7FB081C64CQ40382721-0DC8105F-B1FA-4A26-B64D-098EA857B474Q40544841-D2D74E61-F909-4676-B578-D5CED2B4F654
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan Goldin
@ast
Jonathan Goldin
@en
Jonathan Goldin
@es
Jonathan Goldin
@nl
Jonathan Goldin
@sl
type
label
Jonathan Goldin
@ast
Jonathan Goldin
@en
Jonathan Goldin
@es
Jonathan Goldin
@nl
Jonathan Goldin
@sl
prefLabel
Jonathan Goldin
@ast
Jonathan Goldin
@en
Jonathan Goldin
@es
Jonathan Goldin
@nl
Jonathan Goldin
@sl
P106
P1153
7004374200
P21
P2456
P31
P496
0000-0003-3007-9947